Insights into the origin of ACPAs in RA
- Institution
- Johns Hopkins University, MD
- Principal investigator
- Felipe Andrade
- Funding
- $188K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Citrullination is a physiologic post-translational modification found across multiple normal human tissues. Why this modification is the most important target of antibodies in rheumatoid arthritis (RA) is unknown. While the pathogenic role of anti-citrullinated protein antibodies (ACPAs) remains uncertain, the striking association between ACPAs and RA has raised the possibility that understanding the origin of these antibodies may shed light on the cause of RA. Interestingly, our preliminary studies provide evidence that ACPAs may originate from a distinct antibody targeting a different but structurally similar modification, known as carbamylation. Our overarching hypothesis is that ACPAs can arise during affinity maturation of germline encoded antibodies to carbamylated proteins. In this proposal, we will use RA-derived monoclonal ACPAs to support or discard this novel hypothesis. If the proposal is successful, this work may uncover a mechanism for why citrullinated proteins become immunogenic and potentially to support germline encoded antibodies to carbamylated proteins as initial players in the development of RA.
LOADING MOONBASE SCORE
Questions for Johns Hopkins University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Johns Hopkins UniversityNot yet scored
The antigenic origin of anti-dsDNA antibodies in SLE
Felipe Andrade · $199K · 2024–2026
- NIH · Johns Hopkins UniversityNot yet scored
Izumo1 in remission in SLE
Felipe Andrade · $199K · 2024–2026
- NIH · Johns Hopkins UniversityNot yet scored
The role of cytotoxic T cells in rheumatoid arthritis pathogenesis
Felipe Andrade · $517K · 2021–2026